	US 12,239,766 B2
	Continuous-fiber reinforced biocomposite medical implants
Orahn Preiss-Bloom, Zichron Yakov (IL); Taly Pnina Lindner, Savyon (IL); Eyal Epstein, Tel Aviv (IL); and Danielle Poreh, Herzliyya (IL)
Assigned to OSSIO LTD., Caesarea (IL)
Filed by OSSIO, LTD, Caesarea (IL)
Filed on Aug. 3, 2023, as Appl. No. 18/364,476.
Application 18/364,476 is a continuation of application No. 17/152,165, filed on Jan. 19, 2021, granted, now 11,730,866.
Application 17/152,165 is a continuation of application No. 15/523,389, granted, now 10,926,004, issued on Feb. 3, 2021, previously published as PCT/IB2015/002602, filed on Dec. 28, 2015.
Claims priority of provisional application 62/096,932, filed on Dec. 26, 2014.
Prior Publication US 2024/0115775 A1, Apr. 11, 2024
Int. Cl. A61L 31/12 (2006.01); A61B 17/86 (2006.01); A61F 2/30 (2006.01); A61F 2/44 (2006.01); A61L 27/44 (2006.01); A61L 27/58 (2006.01); A61L 31/06 (2006.01); A61L 31/08 (2006.01); A61L 31/14 (2006.01)

CPC A61L 31/128 (2013.01) [A61B 17/864 (2013.01); A61B 17/866 (2013.01); A61F 2/4455 (2013.01); A61F 2/447 (2013.01); A61L 27/446 (2013.01); A61L 27/58 (2013.01); A61L 31/06 (2013.01); A61L 31/08 (2013.01); A61L 31/148 (2013.01); A61F 2002/30062 (2013.01); A61F 2002/30593 (2013.01); A61F 2002/4495 (2013.01)]

24 Claims

1. A medical implant comprising a biocomposite; wherein the biocomposite comprises a polymer and a plurality of continuous reinforcement fibers; wherein the fibers are aligned in plurality of fiber bundles; wherein said fibers are uni-directionally aligned within each fiber bundle; wherein said polymer is biodegradable and said implant is bioabsorbable; wherein said continuous fibers are longer than 4 mm; and wherein a distance between adjacent reinforcing fibers within the bundle is in the range of 0.5.50 μm.